Stocks · Health care · Pharmaceutical Preparations

Organon & Co.

OGN Clue Score37

United States Fiscal year ends December CIK 0001821825 Results filed 30 Apr 2026

Add to watchlist

What the insiders did Net buying

By person

13 insiders · 3 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Carrie Smith Cox

Executive Chair

$501.76K (1)

—

+$501.76K

90,338

0.0344%

$1.23M

+624.5%

Lynette Holzbaur

SVP and Corporate Controller

$353.08K (1)

—

+$353.08K

52,851

0.0201%

$717.19K

+386.7%

Juliana Papa Drinane

Head of Mfg & Supply

—

$200.31K (1)

−$200.31K

18,475

0.0070%

$250.70K

+50.1%

Kevin Ali

Chief Executive Officer

—

—

—

282,731

0.1077%

$3.84M

+82.0%

Matthew M Walsh

Chief Financial Officer

—

—

—

212,746

0.0810%

$2.89M

+129.7%

Joseph T. Morrissey Jr.

Interim CEO

—

—

—

123,123

0.0469%

$1.67M

+153.3%

Rachel A Stahler

Chief Information Officer

—

—

—

116,105

0.0442%

$1.58M

+101.6%

Aaron Falcione

Chief Human Resources Officer

—

—

—

101,431

0.0386%

$1.38M

+173.9%

Kirke Weaver

Gen. Counsel & Corp. Secy.

—

—

—

92,639

0.0353%

$1.26M

+198.9%

Vittorio Nisita

Head of Global Business Svcs

—

—

—

70,619

0.0269%

$958.30K

+151.1%

Daniel Karp

Executive VP, Corp. Dev.

—

—

—

69,548

0.0265%

$943.77K

+245.9%

Kathryn DiMarco

Corporate Controller

—

—

—

38,740

0.0148%

$525.70K

+66.0%

Ferreira Juan Camilo Arjona

Head of R&D & CMO

—

—

—

37,432

0.0143%

$507.96K

—